1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022) Authors: Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P190 Long-term outcome of bronchial artery embolisation (BAE) for massive haemoptysis. (2nd December 2011) Authors: Adlakha, A; Rupta, R; Sebastian, A; Tait, P; Jackson, J; Ind, P Journal: Thorax Issue: Volume 66(2011)Supplement 4 Page Start: A145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T1 Calcineurin inhibition impairs the dendritic cell transcriptional response to aspergillus fumigatus infection in lung transplant recipients. (15th November 2016) Authors: Adlakha, A; Armstrong-James, DAJ; Lenhard, B Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗